000 01256 a2200337 4500
005 20250514214840.0
264 0 _c20050628
008 200506s 0 0 eng d
022 _a1078-0432
040 _aNLM
_beng
_cNLM
100 1 _aLin, Michael Z
245 0 0 _aThe evolution of antibodies into versatile tumor-targeting agents.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cJan 2005
300 _a129-38 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xchemistry
650 0 4 _aAntigens, Neoplasm
_xchemistry
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aGrowth Substances
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunoconjugates
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aRadioimmunotherapy
_xmethods
650 0 4 _aSensitivity and Specificity
650 0 4 _aSignal Transduction
700 1 _aTeitell, Michael A
700 1 _aSchiller, Gary J
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 11
_gno. 1
_gp. 129-38
999 _c15349862
_d15349862